CompletedNCT04689282
Nasal bioactive factors for children’s speech difficulties
About this title
Read the official source — NCT04689282Interventional studyAges 3–18RussiaADHD
Understand this study
Who was this study for?
Listed age limits: 3 years to 18 years.
- Listed locations
- NovosibirskSee all locations and recruitment
- Study phase
- Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Study information
Study start dateStarted: February 1, 2020
- Recruitment status
- Completed
- Enrollment listed in the registry
- 14
- Sponsor
- Russian Academy of Medical Sciences
- Sponsor type
- Unknown or unclear
- Study type
- Biological
- Intervention type
- Biological
- Study phase
- Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
- Locations
- Russia
- Age range
- From 3 Years to 18 Years
- Official registry ID
- NCT04689282
- Official title
Show the full official title
Safety/Efficacy of Intranasally-Administered Bioactive Factors Produced by M2 Type Macrophages in Children With Developmental Speech Disorders
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Novosibirsk, Russia · Russia
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Russian Academy of Medical Sciences.
Who was this study for?
Listed age limits: 3 years to 18 years.
